Results 1-7 of 7 (Search time: 0.002 seconds).
|2018||Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients||곽혜선||Article|
|2018||Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study||곽혜선||Article|
|2018||Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity||곽혜선; 이정연||Article|
|2019||Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicity||곽혜선; 문진영||Article|
|2017||Expression levels of GABA-A receptor subunit alpha 3, Gabra3 and lipoprotein lipase, Lpl are associated with the susceptibility to acetaminophen-induced hepatotoxicity||임경민||Article|
|2020||Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility||임경민||Article|
|2018||Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner||임경민||Article|